Physician

Jason Mingyi Huang, MD

According to 2025 Medicare claims, Jason Huang, MD (NPI: 1093058059) practices ophthalmology in the Washington, DC-MD market, with the plurality of this provider's patient population coming from The District, DC. This provider's primary affiliated billing organization is THE RETINA GROUP OF WASHINGTON, PLLC (NPI: 1225001654; TIN: 521570295) and primary practice location at 22401-7231. Huang is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Huang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 943 traditional Medicare patients, billed 26,944 HCPCS/CPT codes, and received $2,520,832 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 470 prescription claims across 130 beneficiaries totaling $27,076 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 14 records totaling $521. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $12,859 to $2,520,832. Similarly, Part D prescription costs have moved sharply higher in recent years, from $14,366 to $27,076. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.5M2017 Medicare payment: $12,859 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $7,155 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $57,405 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $770,649 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,141,526 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,594,126 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,262,267 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,520,832 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
201774107$12,859
20186872$7,155
2019239506$57,405
20206094,573$770,649
20217346,918$1,141,526
20229379,243$1,594,126
20231,01515,411$2,262,267
202494326,944$2,520,832

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$14K$27K2015 Drug cost: $14,366 (USD; Tot_Drug_Cst)2016 Drug cost: $8,260 (USD; Tot_Drug_Cst)2017 Drug cost: $9,317 (USD; Tot_Drug_Cst)2018 Drug cost: $6,146 (USD; Tot_Drug_Cst)2019 Drug cost: $6,257 (USD; Tot_Drug_Cst)2020 Drug cost: $5,456 (USD; Tot_Drug_Cst)2021 Drug cost: $26,499 (USD; Tot_Drug_Cst)2022 Drug cost: $22,845 (USD; Tot_Drug_Cst)2023 Drug cost: $23,564 (USD; Tot_Drug_Cst)2024 Drug cost: $27,076 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201574264$14,366
201641149$8,260
201762176$9,317
20184795$6,146
201975163$6,257
20204398$5,456
202177272$26,499
202286296$22,845
2023100370$23,564
2024130470$27,076

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye2191,082$94
92014Established patient complete exam of visual system8592,135$88
92134Imaging of retina8252,111$30
92201Extended exam of the back part of the eye with retinal drawing336429$17
92202Extended exam of the back part of the eye with optic nerve drawing6061,208$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1789,043$10,066
Ketorolac TromethamineKetorolac Tromethamine1004,858$4,433
DifluprednateDifluprednate13379$1,965
Timolol MaleateTimolol Maleate14960$444
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat382,450$388

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$521Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jason Mingyi Huang, MD?

Tedicare shows public-source Medicare data for Jason Mingyi Huang, MD (NPI 1093058059), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jason Mingyi Huang, MD have ACO affiliation data?

Jason Mingyi Huang, MD is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Jason Mingyi Huang, MD?

Jason Mingyi Huang, MD is linked to THE RETINA GROUP OF WASHINGTON, PLLC (billing NPI 1225001654) in the available physician profile data.

Does Jason Mingyi Huang, MD have Open Payments data?

Jason Mingyi Huang, MD has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.